← Back
$ARTV All transactions

Artiva Biotherapeutics, Inc.

F

$ Value

$58K

Shares

14,600

Price

$4

Filed

Feb 18

Insider

Name

Aslan Fred

Title

President and CEO

CIK

0001909362

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-15

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,562,198

Footnotes

Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan. | Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards.

Filing Info

Accession No.

0001193125-26-057667

Form Type

4

Issuer CIK

0001817241

Aslan Fred's History

Date Ticker Type Value
2026-02-15 ARTV A $0
2026-02-15 ARTV F $58K
2025-12-15 ARTV $19K
2025-12-12 ARTV A $0
2025-12-12 ARTV D
2025-12-12 ARTV D
2025-12-12 ARTV D
2025-12-12 ARTV D
2025-12-12 ARTV D
2025-12-12 ARTV D

Other Insiders at ARTV (90d)

Insider Bought Sold Last
Bush Jennifer
COO, CLO, Secy, Compliance Off
2026-02-15
Horan Christopher
Chief Tech Operations Officer
2026-02-15
Sorg Elaine K. 2026-02-18
Aslan Fred
President and CEO
2026-02-15
Raymon Heather
SVP, Research and Development
2026-02-15
Banerjee Subhashis
Chief Medical Officer
2026-02-15